Literature DB >> 16425072

Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava.

Ke-Neng Chen1, Shao-Fa Xu, Zhen-Dong Gu, Wei-Min Zhang, Hong Pan, Wen-Zhong Su, Ji-You Li, Guang-Wei Xu.   

Abstract

Determining the appropriate surgery-based treatment for complicated anterior mediastinal malignancies (CAMM), especially those invading the superior vena cava (SVC) and its branches, remains a challenge for general thoracic surgeons. In this report, we summarize our experience and lessons regarding this issue in order to discuss a reasonable strategy for diagnosis and treatment of CAMM. Between January 2001 and April 2003, 15 patients with CAMM invading the SVC and/or its branches with or without invasion of other neighboring organs were surgically treated in our institution by a single surgeon team. We collected clinical data from the medical charts and from surgeons' specific notes for complicated cases, and performed a comprehensive analysis. There were 9 patients with malignant thymoma. Thymic carcinoma, teratoma, embryonal carcinoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, and mixed teratoma with thymoma were diagnosed in 1 patient each. All procedures were performed via median sternotomy. Some angioplasty techniques were successfully used to resect and reconstruct the SVC. Ten of the 15 patients also underwent pulmonary resection due to involvement of pulmonary parenchyma. Four of the patients underwent perioperative chemotherapy. There were no perioperative deaths. Two patients suffered prolonged ventilation after surgery, and there were no other severe complications related to surgery. One patient died 10 months after surgery. The remaining 14 patients were still living and their progress is still monitored. As of August 2004, the median follow-up duration for all patients was 35 months, and the disease-free survival duration was 10-43 months. CAMM can be safely and completely resected via a median sternotomy, even if it has invaded other mediastinal structures. CAMM should be pathologically identified before initial treatment. A good outcome for patients with CAMM is possible if a suitable strategy combining accurate diagnosis and appropriate treatment, especially surgical resection, is established.

Entities:  

Mesh:

Year:  2006        PMID: 16425072     DOI: 10.1007/s00268-005-0009-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

Review 1.  Unusual radiologic findings in the thorax after radiation therapy.

Authors:  B Mesurolle; S D Qanadli; M Merad; F Mignon; P Baldeyrou; A Tardivon; P Lacombe; D Vanel
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

Review 2.  Cardiac damage following therapeutic chest irradiation. Importance, evaluation and treatment.

Authors:  A Vallebona
Journal:  Minerva Cardioangiol       Date:  2000-03       Impact factor: 1.347

3.  Fine needle aspiration biopsy in the diagnosis of mediastinal lesions.

Authors:  A Rosenberger; O Adler
Journal:  AJR Am J Roentgenol       Date:  1978-08       Impact factor: 3.959

Review 4.  Current status of the diagnosis and treatment of thymoma.

Authors:  G M Graeber; W Tamim
Journal:  Semin Thorac Cardiovasc Surg       Date:  2000-10

5.  Malignant mediastinal germ cell tumors: an intergroup study.

Authors:  D Billmire; C Vinocur; F Rescorla; P Colombani; B Cushing; E Hawkins; W B London; R Giller; S Lauer
Journal:  J Pediatr Surg       Date:  2001-01       Impact factor: 2.545

6.  Primary tumors of the mediastinum.

Authors:  B P Whooley; J D Urschel; J G Antkowiak; H Takita
Journal:  J Surg Oncol       Date:  1999-02       Impact factor: 3.454

Review 7.  Mediastinal lymphoma.

Authors:  J G Strickler; P J Kurtin
Journal:  Semin Diagn Pathol       Date:  1991-02       Impact factor: 3.464

Review 8.  Mediastinal tumors: diagnosis and treatment.

Authors:  C D Wright; D J Mathisen
Journal:  World J Surg       Date:  2001-02       Impact factor: 3.352

9.  Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection.

Authors:  W J Curran; M J Kornstein; J J Brooks; A T Turrisi
Journal:  J Clin Oncol       Date:  1988-11       Impact factor: 44.544

10.  Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded.

Authors:  K Yagi; T Hirata; T Fukuse; H Yokomise; K Inui; O Ike; H Mizuno; M Aoki; S Hitomi; H Wada
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

View more
  6 in total

1.  Reconstruction of mediastinal vessels for invasive thymoma: a retrospective analysis of 25 cases.

Authors:  Yifeng Sun; Chang Gu; Jianxin Shi; Wentao Fang; Qingquan Luo; Dingzhong Hu; Shijie Fu; Xufeng Pan; Yong Chen; Yu Yang; Haitang Yang; Heng Zhao; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Outcomes of extended surgical resections for locally advanced thymic malignancies: a narrative review.

Authors:  Davide Tosi; Francesco Damarco; Sara Franzi; Shehab Mohamed; Alessandro Palleschi; Paolo Mendogni
Journal:  Gland Surg       Date:  2022-03

3.  Thoracoscopic thymectomy with partial superior vena cava resection for locally advanced thymomas.

Authors:  Ning Xu; Zhitao Gu; Chunyu Ji; Xuefei Zhang; Tangbing Chen; Wentao Fang
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Malignant thrombosis of the superior vena cava caused by non-small-cell lung cancer treated with radiation and erlotinib: a case with complete and prolonged response over 3 years.

Authors:  Jianyang Wang; Jun Liang; Wenqing Wang; Han Ouyang; Luhua Wang
Journal:  Onco Targets Ther       Date:  2013-07-01       Impact factor: 4.147

5.  Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases.

Authors:  Erkan Kaba; Berker Özkan; Mehmet Oğuzhan Özyurtkan; Kemal Ayalp; Alper Toker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

Review 6.  Autogenous pericardial angioplasty for thymic malignancies: a narrative review.

Authors:  Hui-Jiang Gao; Guo-Dong Shi; Mao-Jie Pan; Xiao-Tong Liu; Yu-Cheng Wei
Journal:  Mediastinum       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.